|
2026 Journal Article Caring for Australians and <scp>New ZealandeRs</scp> with kidney <scp>Impairment</scp> guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney diseaseAbdy, Mia E., St Pierre, Kitty, Major, Emily, Alexander, Stephen I., Cashmore, Brydee, Coolican, Helen, Cullen, Vanessa, Dawson, Jessica, Lambert, Kelly, Lee, Vincent W., Mallawaarachi, Amali, Rangan, Gopala, Savige, Judy, Varughese, Santosh, Tunnicliffe, David J., Mallett, Andrew J. and the CARI Guidelines Steering Committee (2026). Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease. Internal Medicine Journal imj.70411. doi: 10.1111/imj.70411 |
|
2026 Journal Article Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshopOlsen, William Manning, St Pierre, Kitty, Thompson, Wade, Weir, Kristie Rebecca, Freeman, Christopher Robert, Bohill, Ruth, Farrell, Barbara, Langford, Aili Veronica, O'Donnell, Lisa Kouladjian, Reeve, Emily, Liau, Shin J, McEvoy, Aisling Mary, Shrestha, Shakti, Tesfaye, Wubshet, Breen, Juanita, Etherton-Beer, Christopher, Yik, Jerry, Turner, Justin and Ailabouni, Nagham J. (2026). Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshop. Expert review of clinical pharmacology, 19 (1), 85-96. doi: 10.1080/17512433.2025.2609659 |
|
2025 Journal Article Methods for living guidelines: Paper 6: Insights from ALEC’s use of existing systematic reviews in living guideline developmentSt Pierre, Kitty, Cashmore, Brydee, Cumpston, Miranda S., Hill, Kelvin, McDonald, Steve, Pattuwage, Loyal, White, Heath, Whittle, Samuel L., Turner, Tari and Tunnicliffe, David J. (2025). Methods for living guidelines: Paper 6: Insights from ALEC’s use of existing systematic reviews in living guideline development. Journal of Clinical Epidemiology, 187 111812, 1-13. doi: 10.1016/j.jclinepi.2025.111812 |
|
2025 Journal Article Endpoint selection in autosomal dominant polycystic kidney disease clinical trialsSt Pierre, Kitty, El-Damanawi, Ragada, Jefferis, Julia, Johnson, David W., Hawley, Carmel M., Staatz, Christine E., Viecelli, Andrea K. and Mallett, Andrew J. (2025). Endpoint selection in autosomal dominant polycystic kidney disease clinical trials. Kidney International Reports, 10 (11), 3773-3784. doi: 10.1016/j.ekir.2025.09.024 |
|
2025 Journal Article Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney diseaseSt Pierre, Kitty, El-Damanawi, Ragada, Johnson, David W., Hawley, Carmel M., Viecelli, Andrea K., Jha, Vivekanand, Green, Suetonia C., Gesualdo, Loreto, Kiriwandeniya, Charani, Velayudham, Pushparaj, Vergara, Liza A., Mihala, Gabor, Matsuyama, Misa, Brent, Peta-Ann Paul, Mallett, Andrew J. and IMPEDE-PKD Global Steering Committee (2025). Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease. Trials, 26 (1) 302. doi: 10.1186/s13063-025-09010-6 |
|
2024 Journal Article Interventions for preventing the progression of autosomal dominant polycystic kidney diseaseSt Pierre, Kitty, Cashmore, Brydee A, Bolignano, Davide, Zoccali, Carmine, Ruospo, Marinella, Craig, Jonathan C, Strippoli, Giovanni FM, Mallett, Andrew J, Green, Suetonia C and Tunnicliffe, David J (2024). Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database of Systematic Reviews, 2024 (10) CD010294, CD010294-10. doi: 10.1002/14651858.CD010294.pub3 |
|
2024 Journal Article Metformin for preventing the progression of chronic kidney diseaseEl-Damanawi, Ragada, Stanley, Isabelle Kitty, Staatz, Christine, Pascoe, Elaine M., Craig, Jonathan C., Johnson, David W., Mallett, Andrew J., Hawley, Carmel M., Milanzi, Elasma, Hiemstra, Thomas F. and Viecelli, Andrea K. (2024). Metformin for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews, 2024 (6) CD013414, CD013414. doi: 10.1002/14651858.cd013414.pub2 |
|
2024 Journal Article A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trialsStanley, I. Kitty, Palma, Anton M., Viecelli, Andrea K., Johnson, David W., Hawley, Carmel M., Staatz, Christine E. and Mallett, Andrew J. (2024). A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials. Journal of Nephrology, 37 (5), 1417-1419. doi: 10.1007/s40620-024-01906-x |
|
2024 Journal Article A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR declineStanley, Kitty, Mallett, Andrew J., Viecelli, Andrea K., Hawley, Carmel M., Staatz, Christine E., Johnson, David W. and Milanzi, Elasma (2024). A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline. Kidney International Reports, 9 (5), 1525-1527. doi: 10.1016/j.ekir.2024.02.011 |
|
2022 Journal Article Caring for Australians and New Zealanders With Kidney Impairment guidelines: rapid development of urate lowering therapy guidelines for people with CKDStanley, Isabelle Kitty, Phoon, Richard K. S., Toussain, Nigel D., Cullen, Vanessa, Kearns, John, Dalbeth, Nicola, Johnson, David W., Krishnasamy, Rathika and Tunnicliffe, David J. (2022). Caring for Australians and New Zealanders With Kidney Impairment guidelines: rapid development of urate lowering therapy guidelines for people with CKD. Kidney International Reports, 7 (12), 2563-2574. doi: 10.1016/j.ekir.2022.09.024 |
|
2021 Journal Article Evaluating the utilisation and expenditure patterns of erythropoietin stimulating agents and immunosuppressants in Australian chronic kidney disease patientsStanley, Isabelle Kitty, Schultz, Kadin L., Gardiner, Kyle M. and Staatz, Christine E. (2021). Evaluating the utilisation and expenditure patterns of erythropoietin stimulating agents and immunosuppressants in Australian chronic kidney disease patients. Journal of Pharmaceutical Health Services Research, 12 (3), 350-356. doi: 10.1093/jphsr/rmab027 |
